The Role of Social Determinants of Health in the Receipt of Systemic Treatment for Metastatic Melanoma
Low SES predicted lower systemic treatment receipt for stage IV melanoma at our institution; however, most limitations to treatment came from nonmodifiable barriers to care at the time of diagnosis. These findings provide valuable insight into equity-focused programming at our institution and others.
Authors
- Hailey Seibert (ORCID: https://orcid.org/0000-0003-3545-3766)
- Henry Herrera (ORCID: https://orcid.org/0000-0003-3699-875X)
- Adam C. Wade (ORCID: https://orcid.org/0000-0002-9751-2218)
- Ankit Mangla (ORCID: https://orcid.org/0000-0002-6789-4315)
- Richard S. Hoehn (ORCID: https://orcid.org/0000-0003-1455-6758)
- Maira A Bhatty (ORCID: https://orcid.org/0000-0002-2936-2799)
- Luke Daniel Rothermel (ORCID: https://orcid.org/0000-0001-5700-8028)
- Hanna Kakish (ORCID: https://orcid.org/0000-0002-1282-5443)
- Iris Yeong- Fung Sheng (ORCID: https://orcid.org/0009-0007-4999-6733)
Institutions
- University Hospitals of Cleveland (US)
- University Hospitals Seidman Cancer Center (US)
- Johns Hopkins Hospital (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- American Journal of Clinical Oncology
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1097/coc.0000000000001198
- Citations
- 1
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.05